Bivalirudin in Pediatric Extracorporeal Life Support (ECLS) Patients
Leads
Ursula Adams, MD, MBA
Lauren Brown, DO
IHQI Team
Matt Huemmer, MBA, MHA
Joy Martin, MPH, PMP
Casey Olm-Shipman, MD, MS
Aim
By September 30, 2024, this project will reduce the rate of bleeding and thrombosis complications related to pediatric ECMO (extracorporeal membrane oxygenation). We aim to be at or below the national rates of 20% and 24%, respectively.